Tag: somatic genetic testing market share

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Somatic Genetic Testing Market Growth From $8.88 Billion In 2026 To $14.92 Billion By 2030 At A CAGR Of 13.9%

In recent years, the somatic genetic testing market size has experienced rapid expansion. It is anticipated to increase from $7.78 billion in 2025 to $8.88 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.1%. This historical growth can be attributed to factors such as limited access to genetic testing, a reliance on conventional diagnostic methods, growing awareness of somatic mutations in cancer, increasing hospital and clinical laboratory infrastructure, and rising investment in research institutes.

The somatic genetic testing market is projected for substantial expansion in the coming years. Its valuation is anticipated to reach $14.92 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.9%. This increase during the projected timeframe can be linked to several factors, including progress in NGS and multi-omics technologies, a wider availability of at-home and clinical sequencing services, a rise in precision medicine endeavors, increased government support for genetic testing programs, and the incorporation of AI-powered analytics for interpreting mutations. Key trends expected over the forecast period encompass a greater acceptance of targeted gene panels for cancer and rare conditions, an increased application of Next-Generation Sequencing (NGS) technologies, the expansion of personalized and precision oncology therapies, the broadening of at-home genetic testing options, and the integration of multi-omics data to inform clinical decisions.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=98267785&type=smp&name=Somatic%20Genetic%20Testing%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Somatic Genetic Testing Market Growth Catalysts And Demand Drivers

The somatic genetic testing market is anticipated to expand as a result of the rising prevalence of cancer. Cancer is a collection of diseases characterized by the uncontrolled propagation and dissemination of abnormal cells throughout the body. The increasing burden of cancer is linked to lifestyle choices such as an unhealthy diet, smoking, insufficient physical activity, and excessive alcohol consumption. Somatic genetic testing supports cancer diagnosis by identifying tumor-specific genetic mutations, which facilitates targeted and personalized treatment strategies. It also minimizes invasive procedures through the application of advanced technologies, thus improving diagnostic accuracy and patient outcomes. For instance, in November 2023, the Canadian Cancer Society, a national cancer agency based in Canada, stated that in 2023, an estimated 239,100 Canadians are expected to receive a cancer diagnosis, with approximately 86,700 projected to die from the disease. Therefore, the growing incidence of cancer is a key factor driving the expansion of the somatic genetic testing market.

Somatic Genetic Testing Market Segment Analysis Spotlighting Growth Areas

The somatic genetic testing market covered in this report is segmented –

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

Somatic Genetic Testing Market Trends Shaping Long-Term Demand

Major companies operating in the somatic genetic testing market are primarily focused on developing advanced diagnostic solutions, such as liquid biopsy tests, with the aim of improving accuracy, enabling early detection, and reducing the need for invasive procedures. Liquid biopsy tests refer to non-invasive techniques that analyze circulating tumor DNA (ctDNA) or other biomarkers in blood samples to detect cancer-related genetic mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, which is a next-generation liquid biopsy test designed to identify circulating tumor DNA (ctDNA) from blood samples. The SA74-LB is a comprehensive next-generation sequencing (NGS)-based test developed to detect somatic mutations across 74 key cancer-related genes. This test assists in personalized cancer treatment by identifying actionable mutations, monitoring treatment response, and detecting minimal residual disease (MRD) without requiring traditional tissue biopsies. It supports precision oncology, helping to guide targeted therapies and monitor disease progression or resistance in real-time.

Somatic Genetic Testing Market Leading Companies: Who Holds The Strongest Market Presence?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.

View The Full Somatic Genetic Testing Market Report:

https://thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Somatic Genetic Testing Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Somatic Genetic Testing Market Size, Value And Growth Trends Through 2030

The somatic genetic testing market has experienced swift expansion in recent years, with projections indicating an increase from $7.78 billion in 2025 to $8.88 billion in 2026, representing a compound annual growth rate (CAGR) of 14.1%. This historical growth has been driven by several factors, including restricted availability of genetic testing, dependence on traditional diagnostic approaches, heightened recognition of somatic mutations in cancer cases, enhanced infrastructure within hospitals and clinical laboratories, and growing financial commitments to research institutions.

The somatic genetic testing market is anticipated to experience rapid expansion over the coming years. By 2030, its value is projected to reach $14.92 billion, driven by a compound annual growth rate (CAGR) of 13.9%. This forecast growth is fueled by developments in next-generation sequencing (NGS) and multi-omics technologies, the broadening of both at-home and clinical sequencing options, a rise in precision medicine efforts, increased governmental support for genetic testing programs, and the incorporation of AI-driven analytics to interpret mutations. Among the key trends shaping this period are the growing preference for targeted gene panels to address cancer and rare diseases, the expanding application of NGS techniques, the advancement of personalized and precision oncology therapies, the wider availability of genetic testing kits for home use, and the utilization of multi-omics data to guide clinical decisions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Somatic Genetic Testing Market Growth Drivers: What Factors Are Accelerating Expansion?

The rising occurrence of cancer is anticipated to drive expansion in the somatic genetic testing market moving forward. Cancer is defined as a set of disorders marked by the uncontrolled proliferation and spread of abnormal cells throughout the body. This growing cancer burden stems from lifestyle factors including unhealthy eating habits, tobacco use, lack of physical activity, and heavy alcohol intake. By identifying tumor-specific genetic mutations, somatic genetic testing supports cancer diagnosis, facilitating targeted and customized treatment strategies. It reduces the need for invasive procedures through the application of advanced technologies, enhancing diagnostic precision and patient outcomes. As an example, the Canadian Cancer Society, a national cancer organization based in Canada, reported in November 2023 that an estimated 239,100 Canadians are expected to receive a cancer diagnosis in 2023, with around 86,700 projected to succumb to the illness. Consequently, the escalating incidence of cancer is fueling growth in the somatic genetic testing market.

Somatic Genetic Testing Market Segmentation Trends And Revenue Drivers

The somatic genetic testing market covered in this report is segmented –

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

Somatic Genetic Testing Market Trends: What Is Shaping Future Industry Growth?

Leading players within the somatic genetic testing sector are prioritizing the creation of sophisticated diagnostic tools, particularly liquid biopsy assays, to enhance precision, facilitate early diagnosis, and minimize dependence on invasive procedures. These liquid biopsy techniques involve non-invasive approaches that examine circulating tumor DNA (ctDNA) or various biomarkers present in blood specimens to identify cancer-associated genetic alterations. A notable example occurred in September 2024, when Strand Life Sciences, a genomics and bioinformatics firm based in India, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test. This next-generation liquid biopsy assay is specifically tailored to identify circulating tumor DNA (ctDNA) extracted from blood samples. The SA74-LB represents an extensive next-generation sequencing (NGS)-based test capable of detecting somatic mutations across 74 crucial cancer-related genes. The test supports customized cancer treatment by recognizing actionable mutations, tracking therapeutic responses, and identifying minimal residual disease (MRD) without requiring conventional tissue biopsies. It furthers precision oncology by guiding targeted therapies and offering real-time monitoring of disease advancement or treatment resistance.

Somatic Genetic Testing Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.

Access The Complete Somatic Genetic Testing Market Report:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Somatic Genetic Testing Market Leading Geography: Which Region Generates The Most Revenue?

North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Somatic Genetic Testing Market Size, Value And Growth Trends Through 2030

The somatic genetic testing market has experienced swift expansion in recent years, with projections indicating an increase from $7.78 billion in 2025 to $8.88 billion in 2026, representing a compound annual growth rate (CAGR) of 14.1%. This historical growth has been driven by several factors, including restricted availability of genetic testing, dependence on traditional diagnostic approaches, heightened recognition of somatic mutations in cancer cases, enhanced infrastructure within hospitals and clinical laboratories, and growing financial commitments to research institutions.

The somatic genetic testing market is anticipated to experience rapid expansion over the coming years. By 2030, its value is projected to reach $14.92 billion, driven by a compound annual growth rate (CAGR) of 13.9%. This forecast growth is fueled by developments in next-generation sequencing (NGS) and multi-omics technologies, the broadening of both at-home and clinical sequencing options, a rise in precision medicine efforts, increased governmental support for genetic testing programs, and the incorporation of AI-driven analytics to interpret mutations. Among the key trends shaping this period are the growing preference for targeted gene panels to address cancer and rare diseases, the expanding application of NGS techniques, the advancement of personalized and precision oncology therapies, the wider availability of genetic testing kits for home use, and the utilization of multi-omics data to guide clinical decisions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Somatic Genetic Testing Market Growth Drivers: What Factors Are Accelerating Expansion?

The rising occurrence of cancer is anticipated to drive expansion in the somatic genetic testing market moving forward. Cancer is defined as a set of disorders marked by the uncontrolled proliferation and spread of abnormal cells throughout the body. This growing cancer burden stems from lifestyle factors including unhealthy eating habits, tobacco use, lack of physical activity, and heavy alcohol intake. By identifying tumor-specific genetic mutations, somatic genetic testing supports cancer diagnosis, facilitating targeted and customized treatment strategies. It reduces the need for invasive procedures through the application of advanced technologies, enhancing diagnostic precision and patient outcomes. As an example, the Canadian Cancer Society, a national cancer organization based in Canada, reported in November 2023 that an estimated 239,100 Canadians are expected to receive a cancer diagnosis in 2023, with around 86,700 projected to succumb to the illness. Consequently, the escalating incidence of cancer is fueling growth in the somatic genetic testing market.

Somatic Genetic Testing Market Segmentation Trends And Revenue Drivers

The somatic genetic testing market covered in this report is segmented –

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

Somatic Genetic Testing Market Trends: What Is Shaping Future Industry Growth?

Leading players within the somatic genetic testing sector are prioritizing the creation of sophisticated diagnostic tools, particularly liquid biopsy assays, to enhance precision, facilitate early diagnosis, and minimize dependence on invasive procedures. These liquid biopsy techniques involve non-invasive approaches that examine circulating tumor DNA (ctDNA) or various biomarkers present in blood specimens to identify cancer-associated genetic alterations. A notable example occurred in September 2024, when Strand Life Sciences, a genomics and bioinformatics firm based in India, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test. This next-generation liquid biopsy assay is specifically tailored to identify circulating tumor DNA (ctDNA) extracted from blood samples. The SA74-LB represents an extensive next-generation sequencing (NGS)-based test capable of detecting somatic mutations across 74 crucial cancer-related genes. The test supports customized cancer treatment by recognizing actionable mutations, tracking therapeutic responses, and identifying minimal residual disease (MRD) without requiring conventional tissue biopsies. It furthers precision oncology by guiding targeted therapies and offering real-time monitoring of disease advancement or treatment resistance.

Somatic Genetic Testing Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.

Access The Complete Somatic Genetic Testing Market Report:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Somatic Genetic Testing Market Leading Geography: Which Region Generates The Most Revenue?

North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Somatic Genetic Testing Market In 2026 And 2030?

The market size for somatic genetic testing has seen rapid expansion in recent years. It is projected to increase from $7.78 billion in 2025 to $8.88 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.1%. Historically, this growth can be attributed to various factors such as restricted access to genetic testing, a dependence on conventional diagnostic techniques, growing awareness of somatic mutations in cancer, the expansion of hospital and clinical laboratory infrastructure, and rising investment in research institutes.

The somatic genetic testing market is anticipated to experience substantial growth in the coming years, with projections indicating its size will reach $14.92 billion in 2030, at a compound annual growth rate (CAGR) of 13.9%. This expansion during the forecast period is primarily driven by advancements in next-generation sequencing (NGS) and multi-omics technologies, the widening availability of at-home and clinical sequencing services, an increase in precision medicine initiatives, rising government funding for genetic testing programs, and the integration of AI-based analytics for interpreting mutations. Key trends expected over the forecast horizon include the growing adoption of targeted gene panels for cancer and rare diseases, increased utilization of next-generation sequencing (NGS) technologies, the evolution of personalized and precision oncology treatments, the proliferation of at-home genetic testing solutions, and the incorporation of multi-omics data for clinical decision-making.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

What Major Growth Factors Are Impacting The Somatic Genetic Testing Market?

The escalating occurrence of cancer is projected to stimulate the expansion of the somatic genetic testing market in the future. Cancer encompasses a category of illnesses marked by the unregulated proliferation and dissemination of atypical cells within the body. This growing burden of cancer is attributed to various lifestyle factors, including unhealthy dietary habits, tobacco use, sedentary lifestyles, and heavy alcohol intake. Somatic genetic testing assists in identifying cancer by pinpointing genetic mutations specific to tumors, thereby facilitating precise and individualized treatment strategies. Furthermore, it reduces the need for invasive methods through the application of advanced technologies, enhancing diagnostic precision and improving results for patients. As an illustration, data from November 2023 by the Canadian Cancer Society, a national cancer agency based in Canada, indicated that in 2023, an estimated 239,100 Canadians are anticipated to receive a cancer diagnosis, with approximately 86,700 expected to succumb to the illness. Consequently, the rising occurrence of cancer serves as a significant impetus for the growth of the somatic genetic testing market.

How Is The Somatic Genetic Testing Market Distributed Across Key Segments?

The somatic genetic testing market covered in this report is segmented –

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

Which Trends Are Influencing The Expansion Of The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are concentrating on developing advanced diagnostic solutions, such as liquid biopsy tests, to enhance accuracy, enable early detection, and decrease the necessity for invasive procedures. Liquid biopsy tests refer to non-invasive methods that analyze circulating tumor DNA (ctDNA) or other biomarkers in blood samples to detect cancer-related genetic mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, launched the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a next-generation liquid biopsy test designed to detect circulating tumor DNA (ctDNA) from blood samples. The SA74-LB is a comprehensive next-generation sequencing (NGS)-based test designed to detect somatic mutations across 74 key cancer-related genes. This test aids in personalized cancer treatment by identifying actionable mutations, monitoring treatment response, and detecting minimal residual disease (MRD) without the need for traditional tissue biopsies. It supports precision oncology, helping guide targeted therapies and monitor disease progression or resistance in real-time.

Who Are The Prominent Players Across The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.

Access The Complete Somatic Genetic Testing Market Report:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report

Which Region Accounts For The Highest Share Of The Somatic Genetic Testing Market?

North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Somatic Genetic Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

Browse Through More Reports Similar to the Global Somatic Genetic Testing Market 2026, By The Business Research Company

Smart Workplace Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-workplace-global-market-report

Office Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/office-automation-global-market-report

Smart Windows Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-windows-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Somatic Genetic Testing Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The somatic genetic testing market has experienced rapid growth in its size during recent years. It is anticipated to expand from $7.78 billion in 2025 to $8.88 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.1%. The growth witnessed in the past can be attributed to factors such as limited access to genetic testing, reliance on conventional diagnostic methods, growing awareness of somatic mutations in cancer, increasing hospital and clinical laboratory infrastructure, and rising investment in research institutes.

The somatic genetic testing market is projected to experience substantial expansion over the upcoming years, with an anticipated growth to $14.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.9%. This growth during the forecast period is attributed to several factors, including advancements in NGS and multi-omics technologies, an increase in at-home and clinical sequencing services, the proliferation of precision medicine initiatives, an uptick in government funding for genetic testing programs, and the incorporation of AI-based analytics for interpreting mutations. Key trends expected in this period involve the growing adoption of targeted gene panels for cancer and rare diseases, a surge in the application of next-generation sequencing (NGS) technologies, the development of personalized and precision oncology treatments, the wider availability of at-home genetic testing solutions, and the integration of multi-omics data to inform clinical decisions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

What Key Drivers Are Influencing The Growth Of The Somatic Genetic Testing Market?

The somatic genetic testing market is anticipated to grow due to the increasing occurrence of cancer. Cancer describes a collection of diseases characterized by the uncontrolled proliferation and spread of abnormal cells throughout the body. The escalating burden of cancer stems from lifestyle choices such as inadequate diet, smoking, physical inactivity, and excessive alcohol consumption. Somatic genetic testing assists in cancer diagnosis by identifying tumor-specific genetic mutations, thus enabling targeted and personalized treatment strategies. It reduces the need for invasive procedures by utilizing advanced technologies, thereby enhancing diagnostic accuracy and patient outcomes. For instance, in November 2023, according to the Canadian Cancer Society, a Canada-based national cancer agency, an estimated 239,100 Canadians are expected to be diagnosed with cancer in 2023, with approximately 86,700 projected to die from the disease. Therefore, the rising incidence of cancer is a primary driver for the expansion of the somatic genetic testing market.

What Major Segment Divisions Exist Within The Somatic Genetic Testing Market?

The somatic genetic testing market covered in this report is segmented –

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

How Are Trends Shaping The Direction Of The Somatic Genetic Testing Market?

Companies operating within the somatic genetic testing market are concentrating on developing sophisticated diagnostic solutions, such as liquid biopsy tests. This focus aims to enhance accuracy, facilitate early detection, and lessen the requirement for invasive procedures. Liquid biopsy tests are defined as non-invasive techniques that examine circulating tumor DNA (ctDNA) or other biomarkers present in blood samples to identify genetic mutations linked to cancer. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, introduced its Somatic Advantage 74 Liquid Biopsy (SA74 LB) test. This next-generation liquid biopsy test is designed to detect circulating tumor DNA (ctDNA) from blood samples. The SA74-LB is a comprehensive next-generation sequencing (NGS)-based test, developed to uncover somatic mutations across 74 key cancer-related genes. This test assists in personalized cancer treatment by pinpointing actionable mutations, tracking how patients respond to therapy, and identifying minimal residual disease (MRD), all without requiring traditional tissue biopsies. It supports precision oncology, offering guidance for targeted therapies and allowing real-time monitoring of disease progression or the emergence of resistance.

Which Companies Are Leading Innovation In The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.

Read the full somatic genetic testing market report here:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Somatic Genetic Testing Market?

North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Somatic Genetic Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27421&type=smp

Browse Through More Reports Similar to the Global Somatic Genetic Testing Market 2026, By The Business Research Company

Smart Workplace Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-workplace-global-market-report

Office Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/office-automation-global-market-report

Smart Windows Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-windows-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the somatic genetic testing market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Somatic Genetic Testing Market size between 2026 and 2035?

The somatic genetic testing market has seen a rapid expansion in its size recently. This market is set to expand from $7.78 billion in 2025 to $8.88 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.1%. In the past, this growth was influenced by factors including restricted accessibility to genetic testing, a reliance on traditional diagnostic approaches, an increasing understanding of somatic mutations in cancer, the development of hospital and clinical laboratory infrastructure, and increased funding directed towards research institutions.

The somatic genetic testing market is projected to experience substantial expansion in the coming years, with its valuation expected to reach $14.92 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.9%. This anticipated growth during the forecast period is fueled by several factors, including developments in NGS and multi-omics technologies, the broadening availability of at-home and clinical sequencing services, the proliferation of precision medicine efforts, increased government investment in genetic testing programs, and the incorporation of AI-based analytics for interpreting mutations. Key developments expected over this period encompass a greater uptake of targeted gene panels for both cancer and rare diseases, a wider application of next-generation sequencing (NGS) technologies, the progression of personalized and precision oncology treatments, the wider availability of at-home genetic testing options, and the integration of multi-omics data into clinical decision-making processes.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

Which Drivers Are Impacting Market Performance In The Somatic Genetic Testing Market?

The rising occurrence of cancer is projected to drive the expansion of the somatic genetic testing market in the future. Cancer encompasses various illnesses defined by the unchecked proliferation and dissemination of atypical cells within the body. This growing burden of cancer stems from lifestyle factors like an unhealthy diet, tobacco use, lack of physical activity, and heavy alcohol intake. Somatic genetic testing assists in diagnosing cancer through the identification of genetic mutations specific to tumors, thereby facilitating tailored and individualized treatment strategies. By leveraging sophisticated technologies, it reduces the need for invasive procedures, enhancing both diagnostic precision and patient results. For example, in November 2023, the Canadian Cancer Society, a national cancer agency based in Canada, indicated that an estimated 239,100 Canadians are anticipated to receive a cancer diagnosis in 2023, with roughly 86,700 expected to succumb to the illness. Consequently, the escalating rate of cancer incidence is fueling the expansion of the somatic genetic testing market.

Which Segments Are Contributing To The Growth Of The Somatic Genetic Testing Market?

The somatic genetic testing market covered in this report is segmented –

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

Which Trends Are Influencing The Development Of The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are focusing on developing advanced diagnostic solutions, such as liquid biopsy tests, to enhance accuracy, enable early detection, and reduce the need for invasive procedures. Liquid biopsy tests refer to non-invasive methods that analyze circulating tumor DNA (ctDNA) or other biomarkers in blood samples to detect cancer-related genetic mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a next-generation liquid biopsy designed to identify circulating tumor DNA (ctDNA) from blood samples. The SA74-LB is a comprehensive next-generation sequencing (NGS)-based test engineered to discover somatic mutations across 74 key cancer-related genes. This test assists in personalized cancer treatment by pinpointing actionable mutations, monitoring therapeutic responses, and detecting minimal residual disease (MRD) without needing traditional tissue biopsies. It further supports precision oncology, helping guide targeted therapies and track disease progression or resistance in real-time.

Who Are The Core Companies Influencing Trends In The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report

Which Regions Are Projected To Dominate The Somatic Genetic Testing Market In The Coming Years?

North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Somatic Genetic Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27421&type=smp

Browse Through More Reports Similar to the Global Somatic Genetic Testing Market 2026, By The Business Research Company

Smart Workplace Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-workplace-global-market-report

Office Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/office-automation-global-market-report

Smart Windows Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-windows-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the somatic genetic testing market from 2025–2034 with trusted insights from The Business Research Company

How Is The Somatic Genetic Testing Market Expected To Grow In Terms Of Size?

The somatic genetic testing market size has seen rapid expansion in recent years. It is anticipated to increase from $6.81 billion in 2024 to $7.78 billion in 2025, indicating a compound annual growth rate (CAGR) of 14.3%. This historical growth can be linked to heightened awareness of genetic ailments, a rise in cancer instances, increasing integration of genetic testing in medical facilities, development of healthcare infrastructure, and surging patient requests for customized therapies.

The somatic genetic testing market size is anticipated to experience substantial growth in the upcoming years, with projections indicating an increase to $13.13 billion by 2029, at a compound annual growth rate (CAGR) of 14.0%. This expansion during the forecast period is primarily driven by an increasing focus on early disease identification, burgeoning collaborations between biotech and pharmaceutical companies, the development of more public-private partnerships, and the wider availability of diagnostic instruments. Noteworthy trends expected over this period include advancements in sequencing technology, innovations within bioinformatics and artificial intelligence, increased investment in research and development, the emergence of non-invasive testing methodologies, and breakthroughs in next-generation sequencing platforms.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

What Market Forces Are Contributing To The Growth Of The Somatic Genetic Testing Market?

The rising occurrence of cancer is projected to fuel the expansion of the somatic genetic testing market moving ahead. Cancer describes a range of illnesses defined by the unchecked proliferation and dissemination of atypical cells throughout the body. This growing burden of cancer stems from lifestyle factors like an unhealthy diet, tobacco use, lack of physical activity, and heavy alcohol intake. Somatic genetic testing assists in identifying cancer by pinpointing genetic mutations specific to tumors, thereby facilitating precise and individualized treatment strategies. This testing reduces the need for invasive procedures through the application of advanced technologies, enhancing the precision of diagnosis and improving results for patients. For example, in July 2024, data from the Australian Institute of Health and Welfare, a government agency located in Australia, indicated that the count of cancer cases diagnosed in Australia totaled 160,570 in 2022, signifying an uptick of 3,789 cases from the 156,781 recorded in 2021. Consequently, the escalating occurrence of cancer is a key factor propelling the expansion of the somatic genetic testing market.

How Is The Somatic Genetic Testing Market Segmented Across Key Categories?

The somatic genetic testing market covered in this report is segmented

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Carrier Screening, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Inherited Genetic Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, At-Home Testing Providers, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Carrier Screening: Expanded Carrier Screening, Ethnicity-Based Carrier Screening, Universal Carrier Screening

5) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

What Key Trends Are Driving Growth In The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are focusing on developing advanced diagnostic solutions, such as liquid biopsy tests, to improve accuracy, enable early detection, and reduce the need for invasive procedures. These liquid biopsy tests involve non-invasive methods that analyze circulating tumor DNA (ctDNA) or other biomarkers in blood samples to detect cancer-related genetic mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test. This next-generation liquid biopsy test is designed to detect circulating tumor DNA (ctDNA) from blood samples. The SA74-LB is a comprehensive next-generation sequencing (NGS)-based test created to identify somatic mutations across 74 key cancer-related genes. This test assists in personalized cancer treatment by identifying actionable mutations, monitoring treatment response, and detecting minimal residual disease (MRD) without requiring traditional tissue biopsies. It supports precision oncology, helping to guide targeted therapies and monitor disease progression or resistance in real-time.

Who Are The Major Stakeholders Operating In The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., and Circulogene Theranostics LLC.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report

How Do Regional Dynamics Influence The Somatic Genetic Testing Market Performance?

North America was the largest region in the somatic genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27421&type=smp

Browse Through More Reports Similar to the Global Somatic Genetic Testing Market 2025, By The Business Research Company

Smart Workplace Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-workplace-global-market-report

Smart Windows Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-windows-global-market-report

Cloud Office Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cloud-office-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The Somatic Genetic Testing Market From 2025 To 2034?

The somatic genetic testing market has experienced rapid expansion over recent years. This market is projected to expand from $6.81 billion in 2024 to $7.78 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 14.3%. Historically, this growth has been driven by increased recognition of genetic diseases, the growing incidence of cancer, greater use of genetic testing in medical facilities, enhancements in healthcare infrastructure, and escalating patient requests for tailored treatment options.

The market for somatic genetic testing is projected to expand significantly over the coming years, anticipated to reach a valuation of $13.13 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.0%. Key factors driving this expansion during the forecast period include a heightened focus on early disease identification, an increase in partnerships between biotechnology and pharmaceutical firms, the emergence of more public-private alliances, and the wider availability of diagnostic instruments. Significant trends anticipated during this period encompass advancements in sequencing technology, breakthroughs in bioinformatics and artificial intelligence, increased investment in research and development, the creation of non-invasive testing approaches, and innovations within next-generation sequencing platforms.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

What Are The Drivers Pushing New Developments In The Somatic Genetic Testing Market?

The anticipated rise in cancer cases is poised to boost the expansion of the somatic genetic testing market in the future. Cancer encompasses various conditions marked by the unrestrained proliferation and dissemination of atypical cells throughout the body. This growing burden of cancer is attributed to lifestyle factors including inadequate diet, tobacco use, lack of physical activity, and heavy alcohol intake. Somatic genetic testing assists in identifying cancer by pinpointing genetic mutations specific to tumors, which facilitates tailored and individualized therapeutic strategies. Furthermore, it reduces the need for invasive procedures through the application of sophisticated technologies, thereby enhancing diagnostic precision and patient recovery. As an illustration, data from the Australian Institute of Health and Welfare, an Australia-based government entity, indicated in July 2024 that Australia recorded 160,570 new cancer diagnoses in 2022, representing an uptick of 3,789 cases from the 156,781 reported in 2021. Consequently, the expanding occurrence of cancer is a key catalyst for the growth within the somatic genetic testing market.

What Are The Major Segments Identified In The Somatic Genetic Testing Market?

The somatic genetic testing market covered in this report is segmented

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Carrier Screening, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Inherited Genetic Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, At-Home Testing Providers, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Carrier Screening: Expanded Carrier Screening, Ethnicity-Based Carrier Screening, Universal Carrier Screening

5) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

Which Key Trends Are Expected To Influence The Somatic Genetic Testing Market In The Coming Years?

Major companies operating in the somatic genetic testing market are dedicating efforts to develop advanced diagnostic solutions, including liquid biopsy tests, to enhance accuracy, enable early detection, and lessen the need for invasive procedures. Liquid biopsy tests are non-invasive techniques that analyze circulating tumor DNA (ctDNA) or other biological indicators in blood samples to identify genetic mutations linked to cancer. As an example, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics firm, launched the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a cutting-edge liquid biopsy designed to detect circulating tumor DNA (ctDNA) from blood samples. The SA74-LB is a comprehensive next-generation sequencing (NGS)-based test crafted to identify somatic mutations across 74 crucial cancer-related genes. This test contributes to personalized cancer treatment by pinpointing actionable mutations, monitoring therapy response, and uncovering minimal residual disease (MRD) without requiring traditional tissue biopsies. It supports precision oncology, aiding in guiding targeted therapies and observing disease progression or resistance instantaneously.

Which Global Market Leaders Are Shaping The Future Of The Somatic Genetic Testing Sector?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., and Circulogene Theranostics LLC.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report

Which Regional Markets Are Contributing Most To The Somatic Genetic Testing Industry Expansion?

North America was the largest region in the somatic genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Somatic Genetic Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27421&type=smp

Browse Through More Reports Similar to the Global Somatic Genetic Testing Market 2025, By The Business Research Company

Smart Workplace Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-workplace-global-market-report

Office Automation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/office-automation-global-market-report

Smart Windows Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-windows-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Somatic Genetic Testing Industry?

In recent times, the somatic genetic testing market has witnessed a swift expansion. The market value will rise from $6.81 billion in 2024 to $7.78 billion in 2025, indicating a compound annual growth rate (CAGR) of 14.3%. Factors contributing to the growth during the historic period include rising awareness of genetic ailments, increase in cancer cases, widespread acceptance of genetic testing in medical clinics, improved healthcare infrastructure, and a surge in patients’ demand for tailored treatment.

In the years to come, the somatic genetic testing market is projected to experience a swift growth, reaching a market size of $13.13 billion in 2029 with a compound annual growth rate (CAGR) of 14.0%. Factors contributing to this anticipated growth during the forecast period include an increased focus on early detection of diseases, a surge in collaborations between biotech and pharmaceutical firms, a rise in public-private partnerships, and enhanced accessibility of diagnostic tools. The predicted period will also see trends like advanced technology in sequencing, breakthroughs in bioinformatics and AI, investments in R&D, a surge in non-invasive test methods, and enhancements in next-generation sequencing platforms.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

What Forces Are Driving The Growth Of The Somatic Genetic Testing Industry?

The growth of the somatic genetic testing market is set to be spurred on by the rising prevalence of cancer. Cancer, a term for a collection of diseases defined by the unrestrained growth and proliferation of abnormal cells, is becoming more common due to lifestyle factors such as poor nutrition, smoking, lack of exercise, and excessive drinking. Somatic genetic testing plays a key role in diagnosing cancer by identifying unique genetic mutations in tumors, which allows for tailored treatment options. By employing innovative technology, this form of testing reduces the need for invasive procedures and enhances the precision of diagnoses and the quality of patient outcomes. For instance, data from the Australian Institute of Health and Welfare, a government body in Australia, noted that in July 2024, the number of diagnosed cancer cases in the country had risen to 160,570 in 2022, showing an increase of 3,789 cases from 156,781 the previous year. Given these circumstances, the escalating prevalence of cancer is fuelling the expansion of the somatic genetic testing market.

What Is The Overview Of Market Segmentation In The Somatic Genetic Testing Industry?

The somatic genetic testing market covered in this report is segmented

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Carrier Screening, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Inherited Genetic Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, At-Home Testing Providers, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Carrier Screening: Expanded Carrier Screening, Ethnicity-Based Carrier Screening, Universal Carrier Screening

5) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

What Future Market Trends Are Projected For The Somatic Genetic Testing Industry?

Leading firms in the somatic genetic testing sector are concentrating on developing cutting-edge diagnostic tools, like liquid biopsy tests, to enhance precision, facilitate early detection, and minimize the necessity for invasive techniques. Liquid biopsy tests are non-invasive procedures that examine circulating tumor DNA (ctDNA) or other blood sample biomarkers to identify cancer-linked genetic alterations. For example, in September 2024, Strand Life Sciences, a genomics and bioinformatics firm based in India, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a next-gen liquid biopsy test formulated to determine circulating tumor DNA (ctDNA) from blood specimens. The SA74-LB is a comprehensive next-gen sequencing (NGS)-based test designed to identify somatic mutations across 74 critical cancer-associated genes. This test contributes to personalized cancer therapy by pinpointing actionable mutations, tracking treatment results, and identifying minimal residual disease (MRD) without the requirement for traditional tissue biopsies. It fosters precision oncology, aiding in the direction of targeted therapies and monitoring disease progression or resistance in real-time.

Who Are The Primary Players Operating Across The Global Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., and Circulogene Theranostics LLC.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report

Which Region Offers The Most Growth Potential For The Somatic Genetic Testing Market Through 2029?

North America was the largest region in the somatic genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=27421&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model